These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 18690346

  • 21. The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets.
    Bambace NM, Levis JE, Holmes CE.
    Platelets; 2010; 21(2):85-93. PubMed ID: 20063989
    [Abstract] [Full Text] [Related]

  • 22. Comparison of a new ELISA assay with the flow cytometric assay for platelet vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation in whole blood to assess P2Y(12) inhibition.
    Jakubowski JA, Bourguet N, Boulay-Moine D, Sugidachi A, Yamaguchi S, Barragan P, Zhou C, Moulard M.
    Thromb Haemost; 2012 Feb; 107(2):388-95. PubMed ID: 22186965
    [Abstract] [Full Text] [Related]

  • 23. Functional significance of adenosine 5'-diphosphate receptor (P2Y(12)) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate.
    Goto S, Tamura N, Eto K, Ikeda Y, Handa S.
    Circulation; 2002 May 28; 105(21):2531-6. PubMed ID: 12034661
    [Abstract] [Full Text] [Related]

  • 24. PGE1 and PGE2 modify platelet function through different prostanoid receptors.
    Iyú D, Jüttner M, Glenn JR, White AE, Johnson AJ, Fox SC, Heptinstall S.
    Prostaglandins Other Lipid Mediat; 2011 Feb 28; 94(1-2):9-16. PubMed ID: 21095237
    [Abstract] [Full Text] [Related]

  • 25. Adenosine diphosphate receptors on blood platelets: potential new targets for antiplatelet therapy.
    Rozalski M, Nocun M, Watala C.
    Acta Biochim Pol; 2005 Feb 28; 52(2):411-5. PubMed ID: 15912207
    [Abstract] [Full Text] [Related]

  • 26. Rapid and reversible modulation of platelet function in man by a novel P2Y(12) ADP-receptor antagonist, INS50589.
    Johnson FL, Boyer JL, Leese PT, Crean C, Krishnamoorthy R, Durham T, Fox AW, Kellerman DJ.
    Platelets; 2007 Aug 28; 18(5):346-56. PubMed ID: 17654304
    [Abstract] [Full Text] [Related]

  • 27. The P2Y(12) antagonists, 2MeSAMP and cangrelor, inhibit platelet activation through P2Y(12)/G(i)-dependent mechanism.
    Xiang B, Zhang G, Ren H, Sunkara M, Morris AJ, Gartner TK, Smyth SS, Li Z.
    PLoS One; 2012 Aug 28; 7(12):e51037. PubMed ID: 23236426
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Bubble-induced aggregation of platelets: effects of gas species, proteins, and decompression.
    Thorsen T, Klausen H, Lie RT, Holmsen H.
    Undersea Hyperb Med; 1993 Jun 28; 20(2):101-19. PubMed ID: 8392414
    [Abstract] [Full Text] [Related]

  • 30. Characterisation of species differences in the platelet ADP and thrombin response.
    Nylander S, Mattsson C, Lindahl TL.
    Thromb Res; 2006 Jun 28; 117(5):543-9. PubMed ID: 15921723
    [Abstract] [Full Text] [Related]

  • 31. Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
    Storey RF, May JA, Heptinstall S.
    Thromb Res; 2005 Jun 28; 115(4):301-7. PubMed ID: 15668190
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Decreased VASP phosphorylation in platelets of male and female smokers of young age.
    Assinger A, Schmid W, Volf I.
    Platelets; 2010 Jun 28; 21(8):596-603. PubMed ID: 20822337
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of platelet function, a method comparison.
    Nylander S, Johansson K, Van Giezen JJ, Lindahl TL.
    Platelets; 2006 Feb 28; 17(1):49-55. PubMed ID: 16308187
    [Abstract] [Full Text] [Related]

  • 35. Reference curves for aggregation and ATP secretion to aid diagnose of platelet-based bleeding disorders: effect of inhibition of ADP and thromboxane A(2) pathways.
    Dawood BB, Wilde J, Watson SP.
    Platelets; 2007 Aug 28; 18(5):329-45. PubMed ID: 17654303
    [Abstract] [Full Text] [Related]

  • 36. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
    Béres BJ, Tóth-Zsámboki E, Vargová K, László A, Masszi T, Kerecsen G, Préda I, Kiss RG.
    Thromb Haemost; 2008 Nov 28; 100(5):829-38. PubMed ID: 18989527
    [Abstract] [Full Text] [Related]

  • 37. Platelets possess functional TGF-beta receptors and Smad2 protein.
    Lev PR, Salim JP, Marta RF, Osorio MJ, Goette NP, Molinas FC.
    Platelets; 2007 Feb 28; 18(1):35-42. PubMed ID: 17365852
    [Abstract] [Full Text] [Related]

  • 38. The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function.
    Iyú D, Glenn JR, White AE, Johnson AJ, Fox SC, Heptinstall S.
    Platelets; 2010 Feb 28; 21(5):329-42. PubMed ID: 20433310
    [Abstract] [Full Text] [Related]

  • 39. Differential involvement of the P2Y1 and P2YT receptors in the morphological changes of platelet aggregation.
    Eckly A, Gendrault JL, Hechler B, Cazenave JP, Gachet C.
    Thromb Haemost; 2001 Apr 28; 85(4):694-701. PubMed ID: 11341507
    [Abstract] [Full Text] [Related]

  • 40. Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling.
    Goto S, Tamura N, Ishida H, Ruggeri ZM.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):155-62. PubMed ID: 16386680
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.